` Comparison: 569 vs SYK - Alpha Spread

569
vs
SYK

Over the past 12 months, Vicplas International Ltd has outperformed SYK, delivering a return of +10% compared to the SYK's 4% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
569
SYK
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

Intrinsic Value
0.159 SGD
Undervaluation 45%
Intrinsic Value
Price S$0.087
SYK Intrinsic Value
295.57 USD
Overvaluation 11%
Intrinsic Value
Price $331.54
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
Vicplas International Ltd
SGX:569
0.087 SGD
Stryker Corp
NYSE:SYK
331.54 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
569, SYK

569
SYK
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Vicplas International Ltd
Revenue
Stryker Corp
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
569, SYK

569
SYK
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Vicplas International Ltd
SGX:569
Stryker Corp
NYSE:SYK
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

Vicplas International Ltd
53.1%
SYK
64.6%

Operating Margin

Vicplas International Ltd
0.2%
SYK
22.7%

Net Margin

Vicplas International Ltd
-2%
SYK
12.9%

FCF Margin

Vicplas International Ltd
-5.2%
SYK
17.1%

ROE

Vicplas International Ltd
-3.2%
SYK
15.1%

ROA

Vicplas International Ltd
-1.8%
SYK
7.1%

ROIC

Vicplas International Ltd
0.3%
SYK
10.4%

ROCE

Vicplas International Ltd
0.3%
SYK
15.1%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
569, SYK

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
569, SYK

Loading
569
SYK
Difference
www.alphaspread.com

Performance By Year
569, SYK

Loading
569
SYK
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 569 to other stocks
ABT
Abbott Laboratories
More expensive
vs Vicplas International Ltd
ISRG
Intuitive Surgical Inc
More expensive
vs Vicplas International Ltd
MDT
Medtronic PLC
More expensive
vs Vicplas International Ltd
BSX
Boston Scientific Corp
More expensive
vs Vicplas International Ltd
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett